MAIA Biotechnology, Inc. Increase (Decrease) in Receivables
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2024-03-21
- MAIA Biotechnology, Inc. increase (decrease) in receivables for the quarter ending 2023-12-31 was $16.21K, a 58.66% decline year-over-year.
- MAIA Biotechnology, Inc. increase (decrease) in receivables for the quarter ending 2023-09-30 was -$265.62K, a 507.95% decline year-over-year.
- MAIA Biotechnology, Inc. increase (decrease) in receivables for the quarter ending 2023-06-30 was $39.77K.
- MAIA Biotechnology, Inc. increase (decrease) in receivables for the quarter ending 2023-03-31 was $51.24K.
- MAIA Biotechnology, Inc. increase (decrease) in receivables for fiscal 2023 was -$158.41K, a 158.80% decline from fiscal 2022.
- MAIA Biotechnology, Inc. increase (decrease) in receivables for fiscal 2022 was $269.39K.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 12 month |
|---|---|---|---|---|
| 2023-12-31 | $16.21K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$249.41K derived: sum of 2 quarters · filed 2024-03-21 | -$209.65K derived: sum of 3 quarters · filed 2024-03-21 | -$158.41K 10-K · filed 2024-03-21 |
| 2023-09-30 | -$265.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$225.86K derived: sum of 2 quarters · filed 2023-11-07 | -$174.61K 10-Q · filed 2023-11-07 | -$135.41K derived: sum of 4 quarters · filed 2024-03-21 |
| 2023-06-30 | $39.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $91.01K 10-Q · filed 2023-08-08 | $130.22K derived: sum of 3 quarters · filed 2024-03-21 | $195.33K derived: sum of 4 quarters · filed 2024-03-21 |
| 2023-03-31 | $51.24K 10-Q · filed 2023-05-08 | $90.45K derived: sum of 2 quarters · filed 2024-03-21 | $155.56K derived: sum of 3 quarters · filed 2024-03-21 | |
| 2022-12-31 | $39.21K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $104.32K derived: sum of 2 quarters · filed 2024-03-21 | $269.39K 10-K · filed 2024-03-21 | |
| 2022-09-30 | $65.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $230.19K 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $165.08K 10-Q · filed 2023-08-08 |